Small-molecule inhibitors targeting viral proteins could serve as an effective alternative for controlling the spread of COVID-19 at both individual and community levels. In this vein, a recent study ...

CoV-2 nucleocapsid antibodies to detect exposure to SARS-CoV-2: results from a prospective cohort study on COVID-19 ...

Frequent mutations of SARS-CoV-2 have reduced the effectiveness of vaccines, highlighting the need for mutation-resistant ...

Each organism has a different code and a varying amount of nucleotides. A human has about three billion of them, whereas a virus, such as SARS-CoV-2 has about 30,000. Your genetic sequence can ...

After examining thousands of SARS-CoV-2 variants, Vopson discovered that 98.92% of mutations involved the deletion of nucleotides, while only 1.08% resulted in additions. This pattern, he argues ...

It is important to understand the correlates of protection against SARS-CoV-2 and its variants for future vaccine design. Here, the authors show that the complement system enhances the antibody ...

(Reuters) Chinese researchers have identified a newly discovered bat coronavirus that uses the same cell-surface protein, ACE2, to enter human cells as SARS-CoV-2, the virus responsible for COVID-19.